Therapy Areas: Oncology
BiBBInstruments reports additional US orders during targeted EndoDrill GI launch
17 December 2025 - Swedish cancer diagnostics company BiBBInstruments AB (Spotlight: BIBB) said on Wednesday that it received additional fourth-quarter orders from its US distributor TaeWoong Medical ...
Avacta reports tumour shrinkage and 90% disease control rate for AVA6000 in salivary gland cancer patients
17 December 2025 - Biopharmaceutical company Avacta Therapeutics (AIM: AVCT) on Wednesday reported positive preliminary Phase 1b data for faridoxorubicin (AVA6000) in patients with salivary gland canc...
Anixa Biosciences transfers breast cancer vaccine IND from Cleveland Clinic
16 December 2025 - US biotechnology company Anixa Biosciences Inc (NASDAQ:ANIX) announced on Monday that it has completed the transfer of the Investigational New Drug application (IND) for its breast ...
RedHill Biopharma reports positive opaganib data in venetoclax-resistant CLL
15 December 2025 - Biopharmaceutical company RedHill Biopharma Ltd (Nasdaq: RDHL) on Monday reported positive in vivo results showing that opaganib, when combined with venetoclax, reduced Chronic Lymp...
Genmab completes tender offer for Merus and opens subsequent offering period
12 December 2025 - Copenhagen-based biotechnology company Genmab A/S (Nasdaq: GMAB) on Friday said that all conditions to its USD97-per-share cash tender offer for Dutch oncology company Merus NV (Nas...
NanOlogy launches drug development program for diffuse intrinsic pontine glioma treatment
12 December 2025 - NanOlogy, LLC, a Texas-based, private clinical-stage oncology company, announced on Thursday that it has launched a drug development program aimed at transforming the treatment of d...